ClinVar Miner

Submissions for variant NM_006516.4(SLC2A1):c.287T>C (p.Met96Thr)

dbSNP: rs1643481875
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001051269 SCV001215414 pathogenic GLUT1 deficiency syndrome 1, autosomal recessive 2023-03-23 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Met96 amino acid residue in SLC2A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20129935, 26598494, 30588498). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC2A1 protein function. ClinVar contains an entry for this variant (Variation ID: 847673). This missense change has been observed in individual(s) with clinical features of SLC2A1-related conditions (PMID: 34305802). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 96 of the SLC2A1 protein (p.Met96Thr).
Experimental Epileptology, AG Lerche, Hertie Institute for Clinical Brain Research RCV001449666 SCV001623015 likely pathogenic Childhood onset GLUT1 deficiency syndrome 2 2021-05-19 criteria provided, single submitter research ACMG Criteria: PM2, PM5, PP1, PP3
Genome-Nilou Lab RCV003446600 SCV004173539 likely pathogenic Encephalopathy due to GLUT1 deficiency 2023-04-11 criteria provided, single submitter clinical testing
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV003446600 SCV004801416 likely pathogenic Encephalopathy due to GLUT1 deficiency 2024-03-19 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.